Jiang Xiao-Dan, Dong Qing-Zhe, Li Shen-Ling, Huang Tian-Qiao, Zhang Nian-Kai
Am J Rhinol Allergy. 2017 Jan 1;31(1):51-55. doi: 10.2500/ajra.2017.31.4387.
Sinonasal inverted papilloma (SNIP) is noted for its high rate of recurrence and malignant transformation. Although many clinical studies have demonstrated the effectiveness of the endoscopic approach for SNIP, the surgical strategy has been the subject of much debate.
To evaluate the effectiveness of the endoscopic endonasal approach in SNIP.
A systematic review of patients with a diagnosis of SNIP and who had surgery at our institution from June 2005 to March 2013 was performed. All the patients who had postoperative follow-up for >2 years were enrolled. Each case was categorized into one of four stages as reported by Krouse. Demographic and tumor date, operative approach, complications, and recurrence rates were collected.
A total of 125 patients were included in this study. There were 17 patients in stage 1, 40 in stage 2, 57 in stage 3, and 11 in stage 4. The overall recurrence rate was 8.0%. There was no significant difference in recurrence among the stages (all p > 0.05). Recurrence after endoscopic endonasal approach (8.4%) and a combined endoscopic and open exposure procedure (5.6%) were not significantly different (p > 0.05). The recurrence rate was significantly (p < 0.05) higher in patients with revision (15.6%) than in patients in the primary cases (3.8%). A common site of tumor origin was recorded to be from the maxillary sinus (40.2%). Twenty percent of recurrences were observed up to 5 years after surgery.
Endoscopic surgery may be preferred for treating SNIP. The elevated recurrence rate after revision emphasized the significance of the first surgery. We encourage a follow-up period of at least 5 years.
鼻窦内翻性乳头状瘤(SNIP)以其高复发率和恶变率而闻名。尽管许多临床研究已证明内镜手术治疗SNIP的有效性,但手术策略一直是诸多争论的焦点。
评估鼻内镜下经鼻入路治疗SNIP的有效性。
对2005年6月至2013年3月在我院诊断为SNIP并接受手术治疗的患者进行系统回顾。纳入所有术后随访超过2年的患者。根据Krouse报道,将每个病例分为四个阶段之一。收集人口统计学和肿瘤数据、手术入路、并发症及复发率。
本研究共纳入125例患者。其中1期17例,2期40例,3期57例,4期11例。总复发率为8.0%。各阶段复发率无显著差异(所有p>0.05)。鼻内镜下经鼻入路术后复发率(8.4%)与内镜联合开放手术复发率(5.6%)无显著差异(p>0.05)。再次手术患者的复发率(15.6%)显著高于初次手术患者(3.8%)(p<0.05)。肿瘤常见起源部位为上颌窦(40.2%)。术后5年内观察到20%的复发。
内镜手术可能是治疗SNIP的首选方法。再次手术后复发率升高强调了首次手术的重要性。我们建议至少随访5年。